MILDRONAT (Capsules)

Pregnancy and lactation

Safety of Mildronate^® during pregnancy has not been proven. To avoid possible adverse effects on the fetus drug should not be administered during pregnancy.

Unknown, whether the drug is released in breast milk. If necessary, use Mildronate^® lactation breastfeeding should be discontinued.

Cautions

With careful use of the drug for a long time in patients with chronic liver disease and kidney failure.

Many years of experience in the treatment of acute myocardial infarction and unstable angina in the cardiology departments shows, that Mildronat^® not a first-line drug for acute coronary syndrome.

Use in Pediatrics

In children and adolescents under the age of 18 years the efficacy and safety Mildronate^® in the form of capsules and injectable solution is not installed.

Effects on ability to drive vehicles and management mechanisms

Data on adverse effects Mildronate^® psychomotor speed not available.